Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PATH-03 Paraguay Feasibility Study

NCT: NCT07034092 · NOT_YET_RECRUITING

NCT IDNCT07034092
StatusNOT_YET_RECRUITING
Start Date2027-03
Completion2028-03
SponsorPathfinder Medical (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this study is to evaluate the safety and effectiveness of the ePATH system in the creation of an endovascular AVF (endoAVF) in patients who require or will soon require hemodialysis and are eligible for a fistula.

Frequently Asked Questions

What is PATH-03 Paraguay Feasibility Study?

PATH-03 Paraguay Feasibility Study is a clinical trial registered under NCT07034092. Current status: NOT_YET_RECRUITING.

What is the status of NCT07034092?

The current status of NCT07034092 (PATH-03 Paraguay Feasibility Study) is: NOT_YET_RECRUITING.

When did PATH-03 Paraguay Feasibility Study start?

PATH-03 Paraguay Feasibility Study started on 2027-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑